Tumor entrained neutrophils inhibit seeding in the premetastatic lung.

[1]  D. Metcalf.  The Colony-Stimulating Factors and Cancer , 2013, Cancer Immunology Research.

[2]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[3]  S. Singhal,et al.  Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells. , 2011, American journal of respiratory cell and molecular biology.

[4]  Thijs J. Hagenbeek,et al.  Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes , 2010, Proceedings of the National Academy of Sciences.

[5]  S. McColl,et al.  Multiple functions of CXCL12 in a syngeneic model of breast cancer , 2010, Molecular Cancer.

[6]  H. Moses,et al.  Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. , 2010, Cancer research.

[7]  R. Weinberg,et al.  Tumor-host interactions: a far-reaching relationship. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  G. Cheng,et al.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.

[9]  M. Sormani,et al.  CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. , 2009, European journal of cancer.

[10]  Xin Lu,et al.  Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone* , 2009, The Journal of Biological Chemistry.

[11]  Paul Kubes,et al.  Intravascular immunity: the host–pathogen encounter in blood vessels , 2009, Nature Reviews Immunology.

[12]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[13]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[14]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[15]  J. Kao,et al.  Expression of a Soluble TGF-β Receptor by Tumor Cells Enhances Dendritic Cell/Tumor Fusion Vaccine Efficacy1 , 2008, The Journal of Immunology.

[16]  A. Ben-Baruch,et al.  The inflammatory chemokines CCL2 and CCL5 in breast cancer. , 2008, Cancer letters.

[17]  Y. Toiyama,et al.  Decreased Expression of Monocyte Chemoattractant Protein-1 Predicts Poor Prognosis Following Curative Resection of Colorectal Cancer , 2008, Diseases of the colon and rectum.

[18]  Mallika Singh,et al.  Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression , 2008, Proceedings of the National Academy of Sciences.

[19]  Michael D. Connolly,et al.  Use of Ly6G‐specific monoclonal antibody to deplete neutrophils in mice , 2008, Journal of leukocyte biology.

[20]  V. Kuchroo,et al.  CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[21]  D. Redelman,et al.  The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci , 2007, International journal of experimental pathology.

[22]  Matthew J. Craig,et al.  Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. , 2007, Cancer research.

[23]  K. Hunter,et al.  Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. , 2007, Experimental and molecular pathology.

[24]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[25]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[26]  Christopher Chiu,et al.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.

[27]  A. M. Hicks,et al.  Transferable anticancer innate immunity in spontaneous regression/complete resistance mice , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Gabrilovich,et al.  Role Of Immature Myeloid Cells in Mechanisms of Immune Evasion In Cancer , 2006, Cancer Immunology, Immunotherapy.

[29]  C. Shriver,et al.  Correlations between Serum Monocyte Chemotactic Protein-1 Levels, Clinical Prognostic Factors, and HER-2/neu Vaccine-Related Immunity in Breast Cancer Patients , 2006, Clinical Cancer Research.

[30]  H. Anders,et al.  Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue , 2006, Journal of leukocyte biology.

[31]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[32]  J. D. De Larco,et al.  The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8 , 2004, Clinical Cancer Research.

[33]  P. Allavena,et al.  The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. , 2003, Cancer research.

[34]  L. Coussens,et al.  MMP9 potentiates pulmonary metastasis formation. , 2002, Cancer cell.

[35]  H. Tonouchi,et al.  Profile of Monocyte Chemoattractant Protein-1 Circulating Levels in Gastric Cancer Patients , 2002, Scandinavian journal of gastroenterology.

[36]  H. Schreiber,et al.  Inhibition of tumor growth by elimination of granulocytes , 1995, The Journal of experimental medicine.

[37]  M. Colombo,et al.  Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells. , 1992, Journal of immunology.

[38]  T. Dexter,et al.  A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. , 1990, Blood.

[39]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[40]  F. Patrone,et al.  Mechanisms of tumour cell destruction by PMA-activated human neutrophils. , 1983, Immunology.

[41]  T. Mcclanahan,et al.  Cancer-induced Expansion and Activation of CD11b+Gr-1+ Cells Predispose Mice to Adenoviral-triggered Anaphylactoid-type Reactions. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  Izhak Haviv,et al.  Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.

[43]  V. Kuchroo,et al.  CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. , 2007, Journal of immunology.

[44]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.